NASDAQ:NBRV
Delisted

Nabriva Therapeutics Ag Stock Predictions

etoro logo Buy NBRV
*Your capital is at risk
$1.42
+0 (+0%)
At Close: Nov 24, 2023
Currently predicting for Fri, 5 Jun 2026

NBRV Prediction Chart

NBRV Predictions History

Latest community submissions for NBRV.
Predictor Target Session Target Price Result Direction Accuracy Score
Oskari Mäkinen Oskari Mäkinen @OskariMC3A4kinen.140491
Feb 18, 2020 Bullish $1.56 X 1
Edgardo Zambrao Edgardo Zambrao @EdgardoZambrao.140226
Feb 18, 2020 $1.55 -90.06% $1.56 V 99.36% 3
JS JS Pro
Feb 18, 2020 $1.58 -89.87% $1.56 X 98.72% 2
long long @long.100140
Aug 29, 2019 $2.44 -88.10% $2.05 V 80.98% 0
May 6, 2019 $2.17 -90.31% $2.24 V 96.88% 0
May 2, 2019 $2.72 -87.35% $2.15 V 73.49% 0
May 1, 2019 $3.07 -85.85% $2.17 V 58.53% 0
Apr 24, 2019 $2.79 -90.28% $2.87 V 97.21% 0
Apr 24, 2019 $3.09 -89.23% $2.87 V 92.33% 0
Apr 23, 2019 $4.30 -84.97% $2.86 V 49.65% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NBRV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NABRIVA THERAPEUTICS AG
Nabriva Therapeutics AG
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE